About Us
Aer Therapeutics is a clinical-stage biopharmaceutical company developing a therapeutic solution for muco-obstructive lung diseases.
Our Mission
To revolutionize the treatment of muco-obstructive lung disease through the development and delivery of an innovative, science-driven therapeutic solution to eliminate mucus plugs in the lungs. With a deep dedication to patient well-being, we aim to transform COPD and asthma care and empower individuals to breathe easier, live better, and embrace a brighter future full of possibilities.
The Aer Team
Meet the dedicated professionals behind Aer Therapeutics working to revolutionize respiratory care.
Thomas P. Mathers
Executive Chairman and Interim CEO
John Fahy, MD, MSc
Founder and Chief Clinical Consultant
William Thelin, PhD
SVP, Drug Development
Bernice Kuca
Head, Clinical and Regulatory Operations
Irina Gitlin, PhD
Vice President, Research and Development
Blair Capel
Senior Director, Finance and Administration
Jordan Low
Senior Director, Clinical Operations
Rony Nasrallah
Associate Director, Technical Operations
Board of Directors
John Fahy, MD, MSc
Founder and Chief Clinical Consultant, Aer Therapeutics
Rishi Gupta, JD
Partner, OrbiMed
Thomas P. Mathers
Executive Chairman
Partner, Pappas Capital
Christy Shaffer, PhD
Partner, Hatteras Ventures
Tim Shannon, MD
Partner, Canaan Partners
Get in Touch
Office
8 Davis Dr, Research Triangle Park, NC 27709